CollPlant Biotechnologies Ltd. (CLGN)
0.3203
-0.02
(-6.70%)
USD |
NASDAQ |
Sep 03, 16:00
0.3333
+0.01
(+4.06%)
After-Hours: 19:06
CollPlant Biotechnologies EPS Diluted (Quarterly) : -0.2253 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.2253 |
| December 31, 2025 | -0.2505 |
| September 30, 2025 | -0.2738 |
| June 30, 2025 | -0.2827 |
| March 31, 2025 | -0.1268 |
| December 31, 2024 | -0.3386 |
| September 30, 2024 | -0.3777 |
| June 30, 2024 | -0.3675 |
| March 31, 2024 | -0.3663 |
| December 31, 2023 | -0.4094 |
| September 30, 2023 | -0.3825 |
| June 30, 2023 | 0.4892 |
| March 31, 2023 | -0.3296 |
| December 31, 2022 | -0.3934 |
| September 30, 2022 | -0.395 |
| June 30, 2022 | -0.3865 |
| March 31, 2022 | -0.358 |
| December 31, 2021 | -0.3502 |
| September 30, 2021 | -0.293 |
| June 30, 2021 | -0.2978 |
| March 31, 2021 | 0.88 |
| December 31, 2020 | -0.4202 |
| September 30, 2020 | 0.07 |
| June 30, 2020 | -0.2833 |
| March 31, 2020 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.00 |
| September 30, 2019 | -0.6815 |
| June 30, 2019 | -0.2677 |
| March 31, 2019 | -0.0087 |
| December 31, 2018 | 0.0044 |
| September 30, 2018 | -0.0058 |
| June 30, 2018 | -0.0072 |
| March 31, 2018 | -0.0123 |
| December 31, 2017 | -0.0114 |
| September 30, 2017 | -0.0084 |
| June 30, 2017 | -0.0111 |
| March 31, 2017 | -0.0107 |
| December 31, 2016 | -0.0183 |
| September 30, 2016 | -0.0473 |
| June 30, 2016 | -0.0157 |
| March 31, 2016 | -0.023 |
| December 31, 2015 | -0.0077 |
| September 30, 2015 | -0.0156 |
| June 30, 2015 | -0.0155 |
| March 31, 2015 | -0.0076 |
| December 31, 2014 | -0.0078 |
| September 30, 2014 | -0.0085 |
| June 30, 2014 | -0.0087 |
| March 31, 2014 | -0.0172 |
| December 31, 2013 | -0.0255 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 0.2412 |
| Perspective Therapeutics, Inc. | -0.222 |
| MiMedx Group, Inc. | -0.1004 |
| Regentis Biomaterials Ltd. | -- |
| Xylo Technologies Ltd. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.097M |
| Revenue (Quarterly) | 0.073M |
| Total Expenses (Quarterly) | 3.17M |
| Enterprise Value | 2.974M |
| Gross Profit Margin (Quarterly) | -620.5% |
| Profit Margin (Quarterly) | -4.24K% |
| Earnings Yield | -322.3% |
| Normalized Earnings Yield | -322.26 |